Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: Its association with tumor progression and proliferation

Human Pathology

Volumn 41, Issue 11, 2010, Pages 1507-1515

  Hayashi, Akifumi ^a   Aishima, Shinichi ^a   Miyasaka, Yoshihiro ^a   Nakata, Kohei ^a   Morimatsu, Katsuya ^a   Oda, Yasunori ^a   Nagai, Eishi ^a   Oda, Yoshinao ^a   Tanaka, Masao ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

IPMN; Pdcd4; Progression; Proliferation

Indexed keywords

P21 ACTIVATED KINASE; PROGRAMMED CELL DEATH 4; PROTEIN; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; KI 67 ANTIGEN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR MARKER;

ARTICLE; CELL CYCLE ARREST; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; PANCREAS CANCER; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION; ADENOCARCINOMA; ADENOMA; COLLOID CARCINOMA; EPIDEMIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; JAPAN; METABOLISM; MORTALITY; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PATHOLOGY; SURVIVAL RATE;

ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; ADENOMA; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, PANCREATIC DUCTAL; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; JAPAN; KI-67 ANTIGEN; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; RNA-BINDING PROTEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77957952824     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.02.019     Document Type: Article

References (38)

1. Tanaka M., Kobayashi K., and Mizumoto K. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas J Gastroenterol 40 2005 669 675
2. Furukawa T., Takahashi T., and Kobari M. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping Cancer 70 1992 1505 1513
3. Furukawa T. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas J Hepatobiliary Pancreat Surg 14 2007 233 237
4. Longnecker D.S., Adler G., and Hruban R.H. Intraductal papillary-mucinous neoplasms of the pancreas S.R. Hamilton, L.A. Aaltonen, Pathology and genetics of tumors of the digestive system 2000 IARC Press Lyon 237 240
5. Hruban R.H., Takaori K., and Klimstra D.S. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 2004 977 987
6. Nagai E., Ueki T., and Chijiiwa K. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia." Histochemical and immunohistochemical analysis of 29 cases Am J Surg Pathol 19 1995 576 589
7. Satoh K., Shimosegawa T., and Moriizumi S. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas Pancreas 12 1996 362 368
8. Kitago M., Ueda M., and Aiura K. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas Int J Cancer 110 2004 177 182
9. Semba S., Moriya T., and Kimura W. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas Pancreas 26 2003 250 257
10. Sessa F., Solcia E., and Capella C. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients Virchows Arch 425 1994 357 367
11. Biankin A.V., Biankin S.A., and Kench J.G. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma Gut 50 2002 861 868
12. Miyasaka Y., Nagai E., and Yamaguchi H. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas Clin Cancer Res 13 2007 4371 4377
13. Goke A., Goke R., and Knolle A. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A Biochem Biophys Res Commun 297 2002 78 82
14. Shibahara K., Asano M., and Ishida Y. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death Gene 166 1995 297 301
15. Yoshinaga H., Matsuhashi S., and Fujiyama C. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody Pathol Int 49 1999 1067 1077
16. Soejima H., Miyoshi O., and Yoshinaga H. Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization Cytogenet Cell Genet 87 1999 113 114
17. Azzoni L., Zatsepina O., and Abebe B. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells J Immunol 161 1998 3493 3500
18. Kang M.J., Ahn H.S., and Lee J.Y. Up-regulation of PDCD4 in senescent human diploid fibroblasts Biochem Biophys Res Commun 293 2002 617 621
19. Goke R., Barth P., and Schmidt A. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1) Am J Physiol Cell Physiol 287 2004 C1541 1546
20. Chen Y., Knosel T., and Kristiansen G. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis J Pathol 200 2003 640 646
21. Yang H.S., Matthews C.P., and Clair T. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion Mol Cell Biol 26 2006 1297 1306
22. Wang Q., Sun Z., and Yang H.S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells Oncogene 27 2008 1527 1535
23. Nieves-Alicea R., Colburn N.H., and Simeone A.M. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression Breast Cancer Res Treat 114 2009 203 209
24. Wei Z.T., Zhang X., and Wang X.Y. PDCD4 inhibits the malignant phenotype of ovarian cancer cells Cancer Sci 100 2009 1408 1413
25. Yang H.S., Jansen A.P., and Komar A.A. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation Mol Cell Biol 23 2003 26 37
26. Yang H.S., Knies J.L., and Stark C. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation Oncogene 22 2003 3712 3720
27. Schmid T., Jansen A.P., and Baker A.R. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion Cancer Res 68 2008 1254 1260
28. Biankin A.V., Kench J.G., and Biankin S.A. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence Am J Surg Pathol 28 2004 1184 1192
29. Terada T., Ohta T., and Kitamura Y. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study Arch Pathol Lab Med 122 1998 42 46
30. Bohm M., Sawicka K., and Siebrasse J.P. The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA Oncogene 22 2003 4905 4910
31. Mudduluru G., Medved F., and Grobholz R. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer Cancer 110 2007 1697 1707
32. Wen Y.H., Shi X., and Chiriboga L. Alterations in the expression of PDCD4 in ductal carcinoma of the breast Oncol Rep 18 2007 1387 1393
33. Palamarchuk A., Efanov A., and Maximov V. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein Cancer Res 65 2005 11282 11286
34. Bitomsky N., Wethkamp N., and Marikkannu R siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression Oncogene 27 2008 4820 4829
35. Lankat-Buttgereit B., Lenschen B., and Schmidt H. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells Apoptosis 13 2008 157 164
36. Massague J. G1 cell-cycle control and cancer Nature 432 2004 298 306
37. Seoane J., Le H.V., and Massague J. Myc suppression of p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage Nature 419 2002 729 734
38. Wang Q., Sun Z.X., and Allgayer H. Downregulation of E-cadherin is essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells Oncogene 29 2010 128 138